Tag: Ovarian Cancer
-
New Nanoparticles Stimulate the Immune System to Attack Ovarian Tumors
Reframing Immunotherapy for Ovarian Cancer Immunotherapy has transformed cancer treatment by empowering the body’s own defender — the immune system — to recognize and destroy tumor cells. Yet ovarian cancer has proved streaky ground for many immunotherapies, with tumors often adept at cloaking themselves from immune detection. Recent advances, however, suggest that nanoscale delivery systems…
-
Nanoparticle Breakthrough: A New Strategy to Activate the Immune System Against Ovarian Tumors
New Nanoparticles Spark Immune Response Against Ovarian Tumors Researchers are turning to nanotechnology to overcome a long-standing challenge in cancer immunotherapy: how to effectively stimulate the immune system to recognize and destroy ovarian tumors. A new class of nanoparticles is showing promise by delivering immune-activating signals directly to tumor sites and modulating the tumor microenvironment…
-
Nanoparticles Boost Immune Attack on Ovarian Tumors
New nanoparticle approach aims to strengthen immunotherapy for ovarian cancer Cancer immunotherapy has transformed treatment for several tumor types, but its success with ovarian cancer has been limited. Recent research explores a novel class of nanoparticles designed to prime the immune system and improve anti-tumor responses specifically in ovarian tumors. By delivering immune-stimulating signals directly…
-
Global Analysis Finds Wide Inequalities in Care for Breast, Cervical, and Ovarian Cancers
Overview: A Global Portrait of Cancer Care Gaps A sweeping study by the Cancer Survival Group at the London School of Hygiene & Tropical Medicine exposes persistent disparities in the way three of the most common cancers among women—breast, cervical, and ovarian cancer—are diagnosed and treated around the world. The findings highlight how geography, income…
-
Global Analysis Reveals Stark Inequalities in Care for Breast, Cervical, and Ovarian Cancers
New Global Findings Highlight Widespread Inequities in Cancer Care A landmark study by the Cancer Survival Group at the London School of Hygiene & Tropical Medicine reveals persistent and troubling inequalities in how women’s cancers—breast, cervical, and ovarian—are diagnosed and treated around the world. The research, which analyzed data from diverse health systems, shows that…
-
Global Analysis Uncovers Wide Inequalities in Care for Breast, Cervical, and Ovarian Cancers
Overview A sweeping international study led by the Cancer Survival Group at the London School of Hygiene & Tropical Medicine reveals stark inequalities in how women worldwide experience breast, cervical, and ovarian cancers. The analysis, which examines diagnosis timing, treatment choices, and survival outcomes, underscores the uneven landscape of cancer care across countries and income…
-
Metabolic Syndrome Raises Gynecological Cancer Risk: What This Global Study Reveals
Overview: Metabolic Syndrome and Gynecological Cancers A comprehensive meta-analysis drawing on 25 studies from across the globe shows that women with metabolic syndrome face a notably higher risk of gynecological cancers. The cancers affected include malignancies of the endometrium, ovaries, cervix, vagina, and vulva. The research, conducted by a collaboration involving the Indian Council of…
-
Metabolic Syndrome Raises Gynecological Cancer Risk: Global Study Highlights Need for Prevention
Overview: Metabolic Syndrome and Gynecological Cancer Risk New global research underscores a striking link between metabolic syndrome and an increased risk of gynecological cancers. A meta-analysis drawing on 25 studies from diverse countries shows that women with metabolic syndrome face higher odds of developing cancers of the endometrium, ovaries, cervix, vagina, and vulva. The findings…
-
Metabolic Syndrome Tied to Higher Risk of Gynecological Cancers, New Global Study Finds
New Global Analysis Links Metabolic Syndrome to Higher Gynecological Cancer Risk A comprehensive meta-analysis drawing on 25 studies from countries including India, the United States, China, the United Kingdom, and South Korea finds that women with metabolic syndrome face a significantly higher risk of developing gynecological cancers. The study, led by researchers from the Indian…
-
Engineered CAR T cells show promise against solid tumors
A breakthrough design for solid tumors: CAR T cells deliver IL-12 and PD-L1 blocker Chimeric antigen receptor (CAR) T cell therapy has transformed treatments for certain blood cancers, but solid tumors such as ovarian, prostate, breast, and pancreatic cancers have posed stubborn challenges. A collaborative effort from USC Norris Comprehensive Cancer Center and City of…